Newsfeeds - Spark Newswire

4 minute read

51 Biggest Movers From Yesterday

Today, 5:18 PM

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.

ALLG

1 minute read

Canaccord Genuity Maintains Buy on Castle Biosciences, Lowers Price Target to $80

By Benzinga Newsdesk

Today, 5:18 PM

Canaccord Genuity analyst Kyle Mikson maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and lowers the price target from $94 to $80.

CSTL

2 minute read

FDA
News

Castle Biosciences Receives Advanced Diagnostic Laboratory Test (ADLT) Status For TissueCypher Barrett’s Esophagus Test From The Centers For Medicare & Medicaid Services

By Benzinga Newsdesk

Today, 5:18 PM

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that the Centers for Medicare & Medicaid Services (CMS) granted Advanced Diagnostic

CSTL

10 minute read

Earnings Scheduled For February 28, 2022

By Benzinga Insights

Today, 5:18 PM

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.

AAON

2 minute read

Castle Biosciences Highlights Data On DecisionsDx-Melanoma Published In ‘Future Oncology’

By Benzinga Newsdesk

Today, 5:18 PM

Data demonstrated that patients with a DecisionDx-Melanoma Class 1A (low risk) test result had a five-year recurrence-free survival rate and distant metastasis-free survival rate of 95.8% and 99.2%,

CSTL

1 minute read

SVB Leerink Maintains Outperform on Castle Biosciences, Lowers Price Target to $75

By Benzinga Newsdesk

Today, 5:18 PM

SVB Leerink analyst Puneet Souda maintains Castle Biosciences (NASDAQ:CSTL) with a Outperform and lowers the price target from $85 to $75.

CSTL

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Monday, Nov. 8, 2021: PRLB, COIN, U, CSTL, CLLS

By Benzinga Newsdesk

Today, 5:18 PM

Proto Labs (PRLB) Coinbase Global (COIN) Unity Software (U) Castle Biosciences (CSTL) Cellectis (CLLS)

CLLS

1 minute read

Castle Biosciences Q3 EPS $(0.47) Misses $(0.40) Estimate, Sales $23.48M Beat $22.97M Estimate

By Benzinga Newsdesk

Today, 5:18 PM

Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.40) by 17.5 percent. This is a 104.35 percent decrease over losses of $(0.23) per share

CSTL

12 minute read

Earnings Scheduled For November 8, 2021

By Benzinga Insights

Today, 5:18 PM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.

ACAD

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Tues, Nov. 2, 2021: TSLA, LMT, PLTR, U, CSTL, IOVA, NSTG, PINS

By Benzinga Newsdesk

Today, 5:18 PM

Tesla (TSLA) - 80,100 Lockheed Martin (LMT) - 7,700 Palantir Technologies (PLTR) - 847,901 Unity Software (U) - 178310 Castle Biosciences (CSTL) - 8,174 Iovance

CSTL